Iridex (IRIX) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jul 04 2026 to Jun 28 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Iridex Corp  (NASDAQ: IRIX)

Iridex's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Iridex in the second quarter 2026?
Iridex Corp recorded a cumulative net loss of $-4 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -78.94%.

Within the Medical Equipment & Supplies industry 118 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 3162 to 3320.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jul 04 2026)
II. Quarter		 (Apr 04 2026)
I. Quarter		 (Jan 03 2026)
IV. Quarter		 (Sep 27 2025)
III. Quarter		 (Jun 28 2025)
II. Quarter
Y / Y Equity Change -39.94 % 455.4 % 134.72 % 78.46 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -4 -3 -4 -5 -5
Return On Equity (TTM) -78.94 % -64.23 % -107.47 % -148.64 % -187.33 %
IRIX's Total Ranking # 3320 # 3162 # 3277 # 3396 # 3244
Equity (TTM) in Millions 4 5 5 5 6
Seq. Equity Change -23.1 % -3.86 % 5.15 % -22.74 % 611.15 %
Seq. Net Income Change - - - - -

Back to IRIX Management Effectiveness >> IRIX's 5 Years Annual ROE >> Compare IRIX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 119
Sector # 509
Overall # 3320

Return On Equity Statistics
High Average Low
35.96 %
-44.87 %
-290.57 %
(Jan 03 2015)   (Mar 29 2025)





IRIX Annual Return On Equity (Jan 03 2026)
2026		 (Dec 28 2024)
2024		 (Dec 30 2023)
2023		 (Dec 31 2022)
2022		 (Jan 01 2022)
2021
Total Equity in Millions 5 2 10 17 23
Y / Y Equity Change 134.72 % -77.98 % -44.74 % -26.04 % 2.62 %
Net Income in Millions -4 -9 -10 -8 -5
Y / Y Net Income Change - - - - -
Return On Equity -90.15 % -424.89 % -100.5 % -43.8 % -22.43 %

Back to IRIX Management Effectiveness >> IRIX's 5 Years Annual ROE >> Compare IRIX ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
IRIX's' Return on Equity at Yahoo Finance
IRIX's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for IRIX's Competitors
Subscribers only: Roe for Iridex's Suppliers
Subscribers only: Return On Equity for IRIX's Customers




Companies with similar Return On Equity at Jul 04 2026, within Healthcare Sector ROE

Date modified: 2026-08-19T20:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.